Keyuan Biopharm: Focus on chiral technology, leading the upgrading of the mandelic acid industry.

In the field of fine chemicals, chiral compounds are a key link in pharmaceutical synthesis. Jiangxi Keyuan Biopharm Co., Ltd. has deeply cultivated this niche segment, with biocatalysis technology as its core, dedicated to providing global customers with high value-added chiral intermediate products.

Company Profile: Technology-based, Industry Benchmark

Jiangxi Keyuan Biopharm Co., Ltd. (Securities Abbr: Keyuan Biopharm, Stock Code: 873239.NQ) is a national high-tech enterprise integrating R&D, production, and sales. It is located in Jishan Industrial Park, Pengze County, Jiujiang City, Jiangxi Province—a provincial chemical park approved by the Jiangxi Provincial Government, boasting significant geographical and industrial supporting advantages.

Established in 2011 and listed on the NEEQ in 2019, the company has been successively recognized as a provincial "Specialized, Refined, Differential, and Innovative" (SRDI) SME and a provincial enterprise technology center.

Flagship Products: Focusing on Mandelic Acid Series, Unique Technical Route

Keyuan Bio's core competitiveness lies in its chiral mandelic acid series products, which are key intermediates for synthesizing various chiral drugs, pesticides, and fine chemicals.

The company's flagship product matrix includes:

DL-Mandelic Acid, D-Mandelic Acid, L-Mandelic Acid

o-Chloromandelic Acid, p-Chloromandelic Acid, p-Fluoromandelic Acid, m-Chloromandelic Acid

Other chiral compounds: such as chiral cyanohydrin series, atorvastatin intermediates, diphenylacetonitrile, etc.

It is worth noting that Keyuan Bio has developed various biotechnologies using enzymes as catalysts to synthesize chiral compounds. Compared with traditional chemical synthesis methods, its enzymatic catalysis process offers significant advantages such as mild reaction conditions, high selectivity, and environmental friendliness, reflecting the company's leading position in green manufacturing and technological innovation.

The company possesses large-scale production capabilities for products such as mandelic acid (1000t/a) and o-chloromandelic acid (200t/a), and has expanded into high value-added product lines such as S-phenoxy cyanohydrin, ticagrelor, and clopidogrel intermediates.

Core Advantages: Technical Accumulation and Industrial Clusters

1. Technology and R&D Advantages

As a provincial enterprise technology center, Keyuan Bio possesses profound technical accumulation in the fields of biocatalysis and chiral compound synthesis. The company continuously optimizes and innovates its processes, holding multiple patent technologies surrounding the production workflow, covering core equipment such as distillation units, purification distillation kettles, and gas-liquid separators.

2. Qualifications and Market Recognition

The company has been recognized as a National High-tech Enterprise and awarded the title of provincial "Specialized, Refined, Differential, and Innovative" enterprise. Its product quality and stability enjoy a good reputation in the industry. The products are widely used in pharmaceutical manufacturing, chemical synthesis, and other fields, serving numerous domestic and international customers.

3. Perfect Industrial Supporting Facilities

The company is situated in a provincial chemical park with perfect infrastructure and obvious industrial chain synergy effects. The park is located near mountains and rivers with outstanding location advantages, providing a strong guarantee for the company's continuous and stable production.

Enterprise Contact Information

Address: Jixian Industrial Park, Pengze County, Jiujiang City, Jiangxi Province, China

ChemNet Shop: www.chemnet.com/ChinaSuppliers/14193/

Tel: +86-792-5686966, +86-15390859338

Email: ky1@keyuanchem.com